期刊文献+

血浆同型半胱氨酸与N末端B型利钠肽原联合检测对冠心病患者的临床预测价值 被引量:3

The predictive value of the combination of homocysteine and NT-proBNP on assessment of patients with coronary heart disease
原文传递
导出
摘要 目的 分析血浆同型半胱氨酸(Hcy)与N末端B型利钠肽原(NT-proBNP)联合检测对预测冠心病患者冠状动脉(冠脉)病变及预后的临床价值.方法 选择我院就诊的204例冠心病患者为研究对象,按照临床诊断分为:急性心肌梗死(AMI)组68例,不稳定性心绞痛(UAP)组72例,稳定性心绞痛(SAP)组64例.并选择同期正常健康体检者70例为对照组.检测并比较4组对象Hcy及NT-proBNP水平的差异.根据冠脉造影结果计算并比较3组患者的Gensini积分,随访6个月比较3组患者发生主要不良心脏事件的差异.分析Hcy与NT-proBNP水平与Gensini积分及主要不良心脏事件发生率的相关性.结果 4组Hcy与NT-proBNP浓度以及Gensini评分、主要不良心脏事件发生率比较,差异均有统计学意义(P<0.05),且均为AMI组>UAP组>SAP组>对照组(P值均<0.05);Hcy与NT-proBNP水平与Gensini积分存在相关性,且与主要不良心脏事件发生率有相关性(P值均<0.05).结论 Hcy与NT-proBNP联合检测能反映冠心病患者的冠脉病变程度及有效预测预后. Objective To analyze the predictive value of the combination of homocysteine(Hcy) and NT-proBNP on assessment of coronary lesion and prognostic outcomes of patients with coronary heart disease(CHD).Methods The data of 204 patients with CHD were collected to retrospectively study and divided into three groups,AMI group(68 cases,diagnosis to acute myocardial infarction),UAP group(64 cases,diagnosis to unstable angina pectoris) and SAP group (72 cases,diagnosis to stable angina pectoris),according to clinical diagnosis.And 70 persons,which physical examination was normal,were chosen to control group.The values of Hcy and NT-proBNP were compared among four groups.The scores of Gensini were calculated based on coronary arteriography (CAG) results and compared among three groups.Follow-up 6 months,the occurrence of major adverse cardiac events (MACE) was compared among three groups.The correlations of serum Hcy and NT-proBNP to Gensini scores and the occurrence of MACE were analyzed.Results The serum Hcy,NT-proBNP,Gensini scores and the occurrence of MACE were all different among four groups (P 〈 0.05).The sequences were AMI group 〉 UAP group 〉 SAP group 〉 control group(P 〈 0.05).The positive correlation between serum Hcy,NT-proBNP and Gensini scores was confirmed by Logistic correlation analysis(P 〈0.05).The positive correlations between serum Hcy,NT-proBNP and the occurrence of MACE were confirmed by Logistic regression analysis (P 〈 0.05).Conclusion The predictive value of Hcy and NT-proBNP on assessment of coronary lesion and prognostic outcomes of patients with CHD is perfect.
作者 何小萍
出处 《临床内科杂志》 CAS 2014年第5期324-326,共3页 Journal of Clinical Internal Medicine
关键词 同型半胱氨酸 N末端B型利钠肽原 冠心病 Homocysteine NT-proBNP Coronary heart disease
  • 相关文献

参考文献8

  • 1彭瑞君,黄景文,罗韶金.超敏C-反应蛋白和B型脑钠肽联合应用对急性冠脉综合征患者预后的评估[J].国际医药卫生导报,2009,15(7):14-17. 被引量:5
  • 2Haaf P,Balmelli C,Reichlin T,et al.N-terminal pro-B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction[J] .Am J Med,2011,124(8):731-739.
  • 3Hochholzer W,Morrow DA,Giugliano RP.Novel biomarkers in cardiovascular disease:update 2010[J] .Am Heart J,2010,160 (4):583-594.
  • 4Jensen J,Ma LP,Bjurman C,et al.Prognostic values of NTpro BNP/ BNP ratio in comparison with NTpro BNP or BNP alone in elderly patients with chronic heart failure in a 2-year follow up[J] .Int J Cardiol,2012,155(1):1-5.
  • 5Van Meurs JB,Pare G,Schwartz SM,et al.Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease[J] .Am J Clin N utr,2013,98 (3):668-676.
  • 6邵亮,李南方.脑利钠肽在临床心血管疾病中的应用进展[J].临床心血管病杂志,2007,23(3):164-166. 被引量:15
  • 7Naghshtabrizi B,Shakerian F,Hajilooi M,et al.Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography[J] .J Cardiovasc Dis Res,2012,3 (4):276-279.
  • 8Sabatasso S,Vaucher P,Augsburger M,et al.Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination[J] .Int J Legal Med,2011,125 (6):849-856.

二级参考文献35

  • 1Ridker PM, Morrow DA, Rose LM, et al. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol < 70 mg/dl and C-reactive protein < 2 mg/l: an analysis of the PROVE- IT TIMI-22 trial[J]. J Am Coll Cardiol, 2005,45(10):1644- 1648.
  • 2Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes[]]. Eur J Heart Fail, 2004,6(3):327-333.
  • 3Mega JL, Morrow DA, De Lemos JA, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST- segment elevation myocardial infarction: an ENTIRE-TIMI23 substudy[J]. J Am Coll Cardiol, 2004,44(2):335-339.
  • 4Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes[J]. Am J Cardiol, 2002,89(4):463-465.
  • 5Jernberg T, Stridsberg M, Venge P, et al. N-terminal probrain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation[J]. J Am Coll Cardiol, 2002,40(3):437-445.
  • 6Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease[J]. N Engl J Med, 2000,343(16):1139-1147.
  • 7de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J]. N Engl J Med, 2001,345(14):1014- 1021.
  • 8Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascuLar disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. CircuLation, 2003, L 07 (3):499-511.
  • 9Hartford M, Wiklund O, Mattsson Hulten L, et al. C-reactlve protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes[J]. J Intern Med, 2007,262(5):526-536.
  • 10Nissen SE. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of AtheroscIerosis with Aggressive Lipid Lowering (REVERSAL) trial[J]. Am J Cardiol, 2005,96(5):61- 68.

共引文献17

同被引文献58

  • 1王锋,刘自刚.血脂、超敏C反应蛋白、D-二聚体、同型半胱氨酸联合检测诊断冠心病的临床意义[J].医学信息(医学与计算机应用),2014,0(5):75-75. 被引量:6
  • 2郁志明,杨志健,张笛,洪侃,薛一峰,陆卫红,冯健.冠心病患者血清脂联素和颈动脉内膜中层厚度的关系[J].天津医药,2006,34(11):778-780. 被引量:2
  • 3杨延宗,杜建玲.实用老年内科学[M].北京:华龄出版社,2010:180.
  • 4王吉耀.内科学[M].2版.北京:人民卫生出版社,2012:273.
  • 5Takiuchi S,kamide K,Miwa Y,et al. Diagnostic value of carotid intima-media thickness and plaque score for pre- dicting target organ damage in patients with essential hy- pertension [J]. J Hum Hypertens, 2004,18 (1):17-23.
  • 6Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene,opposes ghrelin's effects on food intake [J]. Science, 2005,310:996-999.
  • 7Lagaud GJ,Young A,Acena A,et al. Obestatin reduces food intake and suppresses body weight gain in rodents [J]. Biochem Biophys Res Commun, 2007,357 (1) : 264-269.
  • 8Green BD, Irwin N, Flatt PR. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice [J]. Peptides, 2007,28 (5) : 981-987.
  • 9Kotani K,Sakane N,Saiga K,et al. Serum ghrelin and carotid atheroselerosis in older Japanese people with metabolic syndrome [J]. Arch Med Res,2006,37(7):903-906.
  • 10Kouk KH,Penttila K, Kemppainen A,et al. C-reactive pror- ein,fibrinogen,interleukin-6 and tumoumecros is factor- alpha in the prognostic classification of unstable angina peetoris [J]. Ann Med,2001,33(1 ) :37-47.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部